← back to search

Mark J. Millan

AVL (France) · FR
🔎 Find collaborators in Cellular and Molecular Neuroscience · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cellular and Molecular Neuroscience · Molecular Biology
Research interest
Research interests include Neurotransmitter Receptor Influence on Behavior, Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, and Neuropeptides and Animal Physiology.
h-index
77
citations
26,641
works
382
NIH funding
primary concept
email

Recent publications

AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1
Science Advances 2024cited by 49position: middledoi
Lipid Dys-Homeostasis Contributes to APOE4-Associated AD Pathology
Cells 2022cited by 16position: middledoi
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Nature Reviews Drug Discovery 2020cited by 959position: lastdoi
Prevention of Psychosis
JAMA Psychiatry 2020cited by 459position: middledoi
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)
European Neuropsychopharmacology 2019cited by 51position: middledoi
Knock-Down of GPR88 in the Dorsal Striatum Alters the Response of Medium Spiny Neurons to the Loss of Dopamine Input and L-3-4-Dyhydroxyphenylalanine
Frontiers in Pharmacology 2019cited by 10position: middledoi
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Nature Reviews Drug Discovery 2018cited by 543position: lastdoi
Deconstructing Vulnerability for Psychosis: Meta-Analysis of Environmental Risk Factors for Psychosis in Subjects at Ultra High-Risk
European Psychiatry 2016cited by 304position: middledoi
Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets
Nature Reviews Drug Discovery 2016cited by 80position: middledoi
Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
European Neuropsychopharmacology 2015cited by 132position: firstdoi
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank: Figure 1.
The International Journal of Neuropsychopharmacology 2015cited by 131position: middledoi
Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, l-DOPA Responsivity, and Glutamatergic Neurotransmission
Journal of Neuroscience 2015cited by 59position: middledoi
Sexual side effects of serotonergic antidepressants: Mediated by inhibition of serotonin on central dopamine release?
Pharmacology Biochemistry and Behavior 2013cited by 85position: middledoi
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Nature Reviews Drug Discovery 2012cited by 1,288position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Andreas Meyer‐Lindenberg · Heidelberg University4 papers (2012–2020)Paolo Fusar‐Poli · King's College London3 papers (2016–2020)Philip McGuire · McGill University3 papers (2016–2020)Silvana Galderisi · Utrecht University3 papers (2016–2020)Dorien H. Nieman · University of Turku2 papers (2019–2020)Christoph U. Correll · Champlain Regional College2 papers (2019–2020)Andrea Pfennig · University of Edinburgh2 papers (2019–2020)Lars Vedel Kessing · University of Gothenburg2 papers (2019–2020)Michael Spedding · University of Edinburgh2 papers (2012–2018)Stefan Borgwardt · Authorised Association Consortium2 papers (2019–2020)Kim Q. · The University of Notre Dame Australia2 papers (2019–2020)Andreas Bechdolf · Humboldt-Universität zu Berlin2 papers (2019–2020)Nikolaos Koutsouleris · King's College London2 papers (2019–2020)Marie‐Odile Krebs · McGill University2 papers (2019–2020)Celso Arango · King's College London2 papers (2019–2020)Thérèse van Amelsvoort · Amsterdam University of Applied Sciences2 papers (2019–2020)Mark A. Geyer · Multidisciplinary Association for Psychedelic Studies2 papers (2012–2016)Guy M. Goodwin · Newcastle upon Tyne Hospital2 papers (2012–2015)Declan Murphy · King's College London1 papers (2012–2012)Baptiste Fourmaux · Université Claude Bernard Lyon 11 papers (2022–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cellular and Molecular Neuroscience · Molecular Biology →